Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy Comparison of Postoperative Symptoms: Gastric Sleeve With and Without Omentopexy. - Trial NCT06396832
Access comprehensive clinical trial information for NCT06396832 through Pure Global AI's free database. This phase not specified trial is sponsored by Instituto Mexicano del Seguro Social and is currently Completed. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 53 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Instituto Mexicano del Seguro Social
Timeline & Enrollment
N/A
May 01, 2022
Apr 01, 2024
Primary Outcome
Postoperative gastrointestinal symptoms
Summary
Metabolic surgery has proven to be an effective treatment for obesity, with laparoscopic
 sleeve gastrectomy being the most popular procedure. Omentopexy (OP) is proposed as a
 strategy to reduce associated complications. Objective was to determine the effectiveness of
 omentopexy in controlling post-surgical symptoms and to measure the need for re-intervention,
 leakage, bleeding, and mortality in patients undergoing laparoscopic sleeve gastrectomy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06396832
Non-Device Trial